Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
What are the next steps in management of IPF exacerbation resistant to steroid therapy?
Related Questions
Would you initiate antifibrotic therapy in a patient with CTD-ILD experiencing worsening symptoms and declining lung function, despite no clear evidence of fibrosis on CT scans?
Is there a role for nintedanib in the management of patients with radiation-induced pulmonary fibrosis?
What is your approach to evaluation and management of GERD in a patient with IPF?
How do you approach management of ILD in the presence of weakly positive RF and ANA but no other objective systemic findings of connective tissue disease?
Would you offer lung SBRT in a patient with Pulmonary Langerhans Cell Histiocytosis (PLCH)?
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
How often do you monitor pulmonary function tests in patients with fibrotic lung disease?
What dose and duration of steroid therapy do you employ while starting mycophenolate in an outpatient with relatively stable CTD-ILD?
How do you determine whether to add abatacept or rituximab to the treatment regimen in patients with mild RA-ILD on methotrexate?
How do you approach a patient with sarcoidosis who cannot tolerate steroids and who is developing ILD?
